More on BNTC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.88 |
|
|||
| Open | $12.88 | ||||
| 52 Wk High | $5.64 | ||||
| 52 Wk Low | $1.20 | ||||
| Day High | $12.88 | ||||
| Day Low | $12.88 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 593 | ||||
- Guggenheim Downgrades Benitec BioPharma (BNTC) to Neutral
- Form 8-K Benitec Biopharma Inc. For: May 22
- Form 4 Benitec Biopharma Inc. For: May 26 Filed by: Friedman David Matthew
- Form 3 Benitec Biopharma Inc. For: May 22 Filed by: Friedman David Matthew
- Benitec BioPharma (BNTC) Reiterated at Market Outperform by Citizens on Q3 Update
- Benitec Biopharma (BNTC) Misses Q3 EPS by 24c
- Form 10-Q Benitec Biopharma Inc. For: Mar 31
- Form 8-K Benitec Biopharma Inc. For: May 14
- Benitec Biopharma reports Q3 2026 results, advances BB-301 trial
- Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
Entities mentioned with BNTC
- FDA | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- S3 | View Related Stories »
- Show More...
